Dermatological conditions during TNF-α-blocking therapy in patients with rheumatoid arthritis: a prospective study
Open Access
- 1 January 2005
- journal article
- research article
- Published by Springer Science and Business Media LLC in Arthritis Research & Therapy
- Vol. 7 (3), R666-R676
- https://doi.org/10.1186/ar1724
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- Survival during treatment with tumour necrosis factor blocking agents in rheumatoid arthritisAnnals Of The Rheumatic Diseases, 2003
- Atopic disorders in ankylosing spondylitis and rheumatoid arthritisAnnals Of The Rheumatic Diseases, 2002
- Frequency of infection in patients with rheumatoid arthritis compared with controls: A population‐based studyArthritis & Rheumatism, 2002
- Etanercept, infliximab, and leflunomide in established rheumatoid arthritis: clinical experience using a structured follow up programme in southern SwedenAnnals Of The Rheumatic Diseases, 2002
- Bullous skin lesions following infliximab infusion in a patient with rheumatoid arthritisArthritis & Rheumatism, 2002
- Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing AgentNew England Journal of Medicine, 2001
- Modified disease activity scores that include twenty-eight-joint counts development and validation in a prospective longitudinal study of patients with rheumatoid arthritisArthritis & Rheumatism, 1995
- SUSPECTED CUTANEOUS DRUG TOXICITY IN RHEUMATOID ARTHRITIS—AN EVALUATIONRheumatology, 1993
- The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritisArthritis & Rheumatism, 1988
- Dermatologic conditions reported in patients with rheumatoid arthritisJournal of the American Academy of Dermatology, 1983